Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Plain language review: the safety of relugolix combination therapy for advanced prostate cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Plain language review: the safety of relugolix combination therapy for advanced prostate cancer.
Plain language review: the safety of relugolix combination therapy for advanced prostate cancer. Future Oncol. 2024 Nov 06; 1-12.
View in:
PubMed
authors with profiles
Michael S Cookson